SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950123-10-012640
Filing Date
2010-02-16
Accepted
2010-02-16 06:21:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a55225sc13g.htm SC 13G 38798
  Complete submission text file 0000950123-10-012640.txt   40618
Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83793 | Film No.: 10602186
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 485 LA JOLLA CA 92037
Business Address
Grasela John (Filed by) CIK: 0001456451 (see all company filings)

Type: SC 13G